0HTG Stock Chart & Stats
$230.68
-$3.56(-1.54%)
At close: 4:00 PM EDT
$230.68
-$3.56(-1.54%)
Day’s Range― - ―
52-Week Range$137.69 - $247.18
Previous CloseN/A
Volume1.15K
Average Volume (3M)2.37K
Market Cap
$53.87B
Enterprise Value$55.01K
Total Cash (Recent Filing)$3.94B
Total Debt (Recent Filing)$8.92B
Price to Earnings (P/E)35.1
Beta0.74
Next Earnings
Aug 11, 2026EPS Estimate
2.42Next Dividend Ex-DateN/A
Dividend Yield0.89%
Share Statistics
EPS (TTM)6.56
Shares Outstanding234,205,860
10 Day Avg. Volume1,744
30 Day Avg. Volume2,371
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)-14.56
Price to Sales (P/S)0.18
P/FCF Ratio21.89
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$262.00Price Target Upside13.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)12.07
Revenue Forecast (FY)$275.63B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowConsistent, large operating and free cash flow provides durable internal funding for operations, M&A, buybacks and debt paydown. Over the next 2–6 months strong cash conversion supports strategic flexibility despite leverage and smooths timing-driven working-capital swings.
High-growth Specialty & Adjacent BusinessesRapid growth in Specialty and adjacent businesses diversifies revenue away from low-margin wholesale distribution. Higher-growth, higher-margin segments and successful integrations (ADS, Solaris/GIA onboarding) change long-term mix and can sustainably lift company profitability and resilience.
Scale And Distribution ReachVery large scale and deep customer relationships create durable competitive advantages in purchasing, service levels and logistics. Scale supports thin distributor economics by enabling favorable supplier terms and broad coverage, underpinning stable core revenue over months ahead.
Bears Say
Weak Balance Sheet / Negative EquityPersistently negative equity and sizable absolute debt reduce financial flexibility and raise refinancing, covenant and rating risks. Over a 2–6 month horizon a thin capital cushion constrains capacity for opportunistic investment and increases vulnerability to macro or policy shocks.
Structurally Thin MarginsVery low distributor margins mean small adverse moves in pricing, reimbursement, tariffs or SG&A can materially depress profitability. Even with recent profit improvement, the business remains margin-sensitive and exposed to cost or mix shifts over the medium term.
Tariff & Asset Impairment RisksA goodwill impairment on Navista signals execution or valuation stress in parts of the MSO strategy, while large tariff payments and uncertain refunds create recurring cash and profit volatility. Regulatory and tariff outcomes pose persistent downside to segment earnings.
Cardinal Health News
0HTG FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest share price was $137.69 and its highest was $247.18 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $53.87B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Aug 11, 2026 which is in 4 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Apr 30, 2026. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.795 by $0.375.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.516 which represents an annual dividend yield of 0.89%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 2.42.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 234,205,860 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $3.17 in its last earnings report, beating expectations of $2.795. Following the earnings report the stock price went down -5.477%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in GB:0HTG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$262.00 (13.58% Upside)
$262.00 (13.58% Upside)
Blogger Sentiment
Bullish
GB:0HTG Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.56%
12-Months-Change
Fundamentals
Return on Equity
0.89%
Trailing 12-Months
Asset Growth
13.67%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
0HTG Company Deck
0HTG Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted broad-based operational strength: solid top-line growth, outsized EPS improvement, robust free cash flow generation, meaningful outperformance in Specialty and other growth businesses, and a raised, narrowed FY26 outlook. Challenges noted include a $184M goodwill impairment for Navista, tariff-related pressure in the GMPD business with uncertain refunds (paid ~ $200M to date), higher headline SG&A and rising interest costs, and revenue mix headwinds from IRA/WAC adjustments and GLP-1 moderation. On balance the company emphasized durable fundamentals, disciplined capital deployment (including $1B of buybacks), successful integration of acquisitions and confidence in long-term targets.View all GB:0HTG earnings summaries0HTG Revenue Breakdown
91.94% Pharmaceutical and Specialty Solutions
5.68% Global Medical Products and Distribution
2.42% Other
-0.04% Corporate

0HTG Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$262.00
▲(13.58% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month










